Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 37/100

Termination Rate

0.0%

0 terminated out of 4 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

50%

1 of 2 completed with results

Key Signals

1 with results100% success

Data Visualizations

Phase Distribution

4Total

Not Applicable (4)

Trial Status

Completed2

Not Yet Recruiting1

Withdrawn1

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 2 completed trials

Clinical Trials (4)

Showing 4 of 4 trials

NCT07433491Not ApplicableNot Yet Recruiting

Blue-blocking Glasses for Sleep Disorders in Child and Adolescent Psychiatry

NCT05994261Not ApplicableCompleted

Cereset Research Long-Term Healthcare Worker Study

NCT04682197Not ApplicableCompleted

Cereset Research In Healthcare Workers During COVID-19

NCT05229107Not ApplicableWithdrawn

Cereset Research For Chronic Nausea

Showing all 4 trials

Hyperarousal